ProfileGDS4718 / 217764_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 77% 77% 97% 80% 87% 72% 87% 75% 89% 82% 83% 88% 79% 84% 81% 84% 75% 93% 81% 98% 85% 82% 85% 79% 84% 84% 78% 85% 62% 68% 75% 95% 77% 81% 93% 90% 82% 88% 77% 99% 71% 79% 99% 88% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.5287577
GSM549102patient 115, normal, homogenized [OPG study]7.4680777
GSM549104patient 119, normal, homogenized [OPG study]11.199997
GSM549108patient 138, normal, homogenized [OPG study]7.705380
GSM549119patient 077, normal, homogenized [OPG study]8.7716887
GSM549133patient 032, cancer, homogenized [OPG study]7.1609572
GSM549139patient 042, cancer, homogenized [OPG study]8.7923487
GSM549099patient 107, normal, homogenized [OPG study]7.2291675
GSM549109patient 139, normal, homogenized [OPG study]9.0387589
GSM549110patient 046, normal, homogenized [OPG study]8.1002782
GSM549114patient 063, normal, homogenized [OPG study]8.3343683
GSM549122patient 082, normal, homogenized [OPG study]8.8511488
GSM549134patient 033, cancer, homogenized [OPG study]7.7364979
GSM549136patient 036, cancer, homogenized [OPG study]8.4116784
GSM549140patient 044, cancer, homogenized [OPG study]8.0194881
GSM549111patient 047, normal, homogenized [OPG study]8.361384
GSM549113patient 057, normal, homogenized [OPG study]7.4388975
GSM549132patient 031, cancer, homogenized [OPG study]9.6888893
GSM549137patient 038, cancer, homogenized [OPG study]7.9759481
GSM549142patient 047, cancer, homogenized [OPG study]10.986698
GSM549100patient 110, normal, homogenized [OPG study]8.4536485
GSM549107patient 135, normal, homogenized [OPG study]8.1802582
GSM549115patient 068, normal, homogenized [OPG study]8.6040585
GSM549116patient 072, normal, homogenized [OPG study]7.7696879
GSM549120patient 078, normal, homogenized [OPG study]8.3959984
GSM549131patient 030, cancer, homogenized [OPG study]8.4804884
GSM549118patient 074, normal, homogenized [OPG study]7.6453878
GSM549129patient 027, cancer, homogenized [OPG study]8.4140585
GSM549123patient 088, normal, homogenized [OPG study]6.2895262
GSM549124patient 006, cancer, homogenized [OPG study]6.6760768
GSM549126patient 015, cancer, homogenized [OPG study]7.291775
GSM549128patient 025, cancer, homogenized [OPG study]10.296595
GSM549103patient 117, normal, homogenized [OPG study]7.3924377
GSM549117patient 073, normal, homogenized [OPG study]8.0193881
GSM549138patient 041, cancer, homogenized [OPG study]9.744993
GSM549141patient 045, cancer, homogenized [OPG study]9.2400790
GSM549130patient 028, cancer, homogenized [OPG study]8.0090982
GSM549101patient 111, normal, homogenized [OPG study]8.8480188
GSM549105patient 128, normal, homogenized [OPG study]7.5293277
GSM549106patient 134, normal, homogenized [OPG study]12.144199
GSM549112patient 048, normal, homogenized [OPG study]6.9899571
GSM549125patient 011, cancer, homogenized [OPG study]7.7250379
GSM549127patient 024, cancer, homogenized [OPG study]12.10299
GSM549135patient 035, cancer, homogenized [OPG study]8.896888